ARKAITZ
CARRACEDO PEREZ
INVESTIGADOR/A DISTINGUIDO/A
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Vall d'Hebron (5)
2017
-
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
Oncogene, Vol. 36, Núm. 19, pp. 2737-2749
2016
-
Stratification and therapeutic potential of PML in metastatic breast cancer
Nature Communications, Vol. 7
2015
-
Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN
Methods, Vol. 77, pp. 25-30
2008
-
Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors
Cell Cycle, Vol. 7, Núm. 24, pp. 3805-3809
-
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
Journal of Clinical Investigation, Vol. 118, Núm. 9, pp. 3065-3074